Unease permeates the stock market. From regulatory rulings to blocked mergers, the attitude from -- and about -- Washington is very different this year.
Jim Cramer focuses on Merck, Eli Lilly, Abbott Labs, Phillips 66, Five Below, and Cintas in the Lightning Round.
Do we trade on the news out of Washington? Jim Cramer talks about Larry Kudlow and his stand on economic growth.